Ring Mountain Capital’s AbbVie ABBV Stock Holding History

Ring Mountain Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$410K	Buy	1,885 +10	+0.5%	+$2.22K	0.22%	60
2025 Q4	$402K	Buy	1,875 +15	+0.8%	+$3.42K	0.21%	61
2025 Q3	$431K	Sell	1,860 -21	-1%	-$4.28K	0.24%	56
2025 Q2	$356K	Buy	1,881 +10	+0.5%	+$1.86K	0.22%	62
2025 Q1	$392K	Buy	1,871 +67	+4%	+$13K	0.29%	54
2024 Q4	$321K	Buy	+1,804	New	+$332K	0.21%	66

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ring Mountain Capital's ABBV Position: Q1 2026 in Review

Ring Mountain Capital increased its AbbVie (ABBV) stake by 0.53% in Q1 2026, buying an estimated $2.22K and bringing the position to 1,885 shares worth $410K. The position accounts for 0.22% of the portfolio, ranked #60.

Ring Mountain Capital first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $431K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Ring Mountain Capital held 1,885 shares of AbbVie worth $410K as of Q1 2026.
Ring Mountain Capital bought 10 AbbVie shares in Q1 2026, an estimated $2.22K.
AbbVie made up 0.22% of Ring Mountain Capital's portfolio in Q1 2026, its #60 holding.
Ring Mountain Capital first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Ring Mountain Capital's AbbVie position peaked at $431K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ring Mountain Capital's 13F filing for Q1 2026, filed 1 May 2026.